✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Ferrous bisglycinate is an investigational drug.
There have been 3 clinical trials for Ferrous bisglycinate. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2017.
The most common disease conditions in clinical trials are Anemia, Anemia, Iron-Deficiency, and Deficiency Diseases. The leading clinical trial sponsors are GlaxoSmithKline, Assiut University, and Hatem AbuHashim.
Recent Clinical Trials for Ferrous bisglycinate
|Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia||Assiut University||Phase 3|
|Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women||Hatem AbuHashim||Phase 3|
|A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.||GlaxoSmithKline||Phase 3|